Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter

Re: Letter ..Jscala, you may have misread....

in response to by
posted on Apr 10, 2008 12:55PM

the statement regarding dividends.  By stating that Patriot will "continue to hold further dividend distributions", he meant to say that they will hold off for the time being from issuing new dividends which may have been the only thing of good value in the entire letter.

 

God Bless

marc 

Share
New Message
Please login to post a reply